Overview

Reliability of a Top Mount Actuation Indicator With Levalbuterol MDI in Adult and Pediatric Subjects With Asthma or COPD

Status:
Completed
Trial end date:
2006-03-01
Target enrollment:
Participant gender:
Summary
This is a study to investigate the reliability, ruggedness and safety of the top mounted actuation indicator (TMAI) when used with Levalbuterol HFA MDI.
Phase:
Phase 3
Details
Lead Sponsor:
Sunovion
Treatments:
Albuterol